Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.9.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.9.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.9.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.9.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.9.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
XDK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
XDK.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
XDK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
XDK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
XDK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
XDK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
XDK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.6.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.6.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.6.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.6.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used